These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9137683)

  • 1. [Monoclonal immunoglobulins].
    Brouet JC
    Ann Med Interne (Paris); 1996; 147(8):567-9. PubMed ID: 9137683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Waldenstrom's macroglobulinemia.
    McMaster ML
    Semin Oncol; 2003 Apr; 30(2):146-52. PubMed ID: 12720125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
    Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
    Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of monoclonal antibodies to define different stages of maturation of B cells in Waldenström's macroglobulinemia.
    Volpe S; Cantore N; Fotino A; Pagnini D; Volpe E
    Haematologica; 1985; 70(3):274. PubMed ID: 3932166
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of antibody specificity of the monoclonal component in a case of Waldenström's macroglobulinemia].
    Giovanna Zaninetta M; Moccia F; Paolo Mazzarello G; Mansuino P; Morra L
    Ann Ital Med Int; 1992; 7(1):42-5. PubMed ID: 1524946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-smooth-muscle antibody activity of monoclonal IgM in Waldenström's disease].
    Krulik M; Vittecoq D; Abuaf N; Genot JY; Homberg JC; Debray J
    Sem Hop; 1983 Jun; 59(23):1737-41. PubMed ID: 6308799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Waldenström's macroglobulinemia].
    Arderiu Freixa A; Ordi Ros J; Mirada Canals A
    Rev Clin Esp; 1981 Nov; 163(3):151-6. PubMed ID: 6799992
    [No Abstract]   [Full Text] [Related]  

  • 9. Low molecular weight IgM-immunoglobulins in Waldenström's macroglobulinemia.
    Dammacco F; Giustino V; Bonomo L
    Prog Immunobiol Stand; 1970; 4():205-8. PubMed ID: 4991583
    [No Abstract]   [Full Text] [Related]  

  • 10. IgM heavy chain fragments in Waldenström's macroglobulinemia.
    Bhoopalam N; Lee BM; Yakulis VJ; Heller P
    Arch Intern Med; 1971 Sep; 128(3):437-40. PubMed ID: 4999186
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma, Waldenström's macroglobulinemia, and benign monoclonal gammopathy: characteristics of the B cell clone, immunoregulatory cell populations and clinical implications.
    Mellstedt H; Holm G; Björkholm M
    Adv Cancer Res; 1984; 41():257-89. PubMed ID: 6428176
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waldenström's macroglobulinemia in monozygotic twins.
    Fine JM; Muller JY; Rochu D; Marneux M; Gorin NC; Fine A; Lambin P
    Acta Med Scand; 1986; 220(4):369-73. PubMed ID: 3099545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waldenström's macroglobulinemia with prominent splenomegaly and multiple immune disorders.
    Delmer A; Garban F; Le Tourneau A; Conard J; Weiss L; Diebold J; Zittoun R
    Haematologica; 1993; 78(6):408-10. PubMed ID: 8175037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
    Owen RG
    Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody activity of human monoclonal immunoglobulins].
    Seligmann M; Brouet JC
    Pathol Biol (Paris); 1990 Oct; 38(8):822-3. PubMed ID: 2125715
    [No Abstract]   [Full Text] [Related]  

  • 18. The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens.
    Dimopoulos MA; Kastritis E; Delimpassi S; Zomas A; Kyrtsonis MC; Zervas K
    Haematologica; 2008 Sep; 93(9):1420-2. PubMed ID: 18641029
    [No Abstract]   [Full Text] [Related]  

  • 19. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E
    Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical proteomics: study of a cryogel.
    Robert D; Barelli S; Crettaz D; Bart PA; Schifferli JA; Betticher D; Tissot JD
    Proteomics; 2006 Jul; 6(13):3958-60. PubMed ID: 16718732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.